Ethics and psychedelic drugs.
American Psychologist June 1, 1968 Peer reviewed DOI: 10.1037/h0037712 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature Therapeutic Advances in Psychopharmacology • July 1, 2026 • via OpenAlex
- Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation PLoS ONE • June 18, 2026 • via OpenAlex
- E8‑Based Neurochemical Simulation Accelerates Psilocybin Therapy for Cocaine Addiction — E8 Intelligence Research Zenodo (CERN European Organization for Nuclear Research) • May 29, 2026 • via OpenAlex
- Ayahuasca use and improvements in suicidal behavior: An exploratory qualitative study Psychedelics • May 16, 2026 • via OpenAlex
- Baseline Resilience as a Predictor of Ayahuasca Acute Effects and Moderator of the Relationship between Acute Effects and Psychospiritual Outcomes Psychedelic Medicine • May 9, 2026 • via OpenAlex